Pune: At least 28 students of the SM Dr DY Patil English Medium School in Shahunagar of Pimpri Chinchwad were rushed to hospital for suspected food poisoning on Thursday.
The incident occurred around 12.30pm after the students ate sandwiches provided by the school administration during a food festival organised on campus.
Dr Dhananjay Patil of the Chetana Hospital, where the students were taken, told TOI, "The majority of students brought here complained of stomach pain, vomiting, dizziness and headache due to suspected food poisoning.
They were admitted for some time for observation, while six of them were given saline."
Abhay Kotkar, president of the Shikshan Maharshi Dr DY Patil Shikshan Sanstha, told TOI, "All the students taken to hospital were discharged before 6pm on the same day and all were in a stable condition." He added that the sandwiches were given to 330 students studying in Stds V and VI during the food festival, and 28 of them complained of health problems.
Kotkar said, "Immediately after we noticed some students suffering from health issues, we rushed them to hospital in school vans and other vehicles available at the spot. We also sent messages to those who had already reached home after the programme to go to a hospital in case they had a similar problem."
Officials of the Food and Drugs Administration (FDA) collected samples of the food from the school, and reports will reveal whether it was a case of food poisoning, said Kotkar, adding, "We organize various events in our school and mostly offer packaged food to students. However, this time it was decided to give them sandwiches for which the bread and other material were brought from the market, and teachers made the sandwiches in the school itself."
Speaking about the incident, deputy commissioner of police (DCP) Shivaji Pawar told TOI, "After the preliminary treatment, all students were discharged from hospital. Of the 28 who were stricken with the issues, two to three students complained of vomiting; the rest suffered from dizziness and stomach pain."
He added, "We will decide on a further course of action after the FDA's report."
(With inputs from Mihir Tanksale)